Brainstorm Cell Therapeutics, Inc. (BCLI)
0.98
-0.08
(-7.55%)
USD |
OTCM |
Aug 21, 16:00
Brainstorm Cell Therapeutics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 28, 2019 | 17.36 |
| June 27, 2019 | 17.49 |
| June 26, 2019 | 17.18 |
| June 25, 2019 | 17.54 |
| June 24, 2019 | 17.62 |
| June 21, 2019 | 17.75 |
| June 20, 2019 | 16.88 |
| June 19, 2019 | 16.61 |
| June 18, 2019 | 16.33 |
| June 17, 2019 | 16.22 |
| June 14, 2019 | 15.95 |
| June 13, 2019 | 16.13 |
| June 12, 2019 | 15.95 |
| June 11, 2019 | 15.91 |
| June 10, 2019 | 15.91 |
| June 07, 2019 | 15.78 |
| June 06, 2019 | 15.91 |
| June 05, 2019 | 15.78 |
| June 04, 2019 | 16.04 |
| June 03, 2019 | 16.17 |
| May 31, 2019 | 16.08 |
| May 30, 2019 | 16.44 |
| May 29, 2019 | 16.30 |
| May 28, 2019 | 16.48 |
| May 24, 2019 | 16.24 |
| Date | Value |
|---|---|
| May 23, 2019 | 16.39 |
| May 22, 2019 | 16.57 |
| May 21, 2019 | 16.57 |
| May 20, 2019 | 16.57 |
| May 17, 2019 | 17.10 |
| May 16, 2019 | 16.83 |
| May 15, 2019 | 17.45 |
| May 14, 2019 | 17.14 |
| May 13, 2019 | 17.01 |
| May 10, 2019 | 17.36 |
| May 09, 2019 | 17.67 |
| May 08, 2019 | 17.71 |
| May 07, 2019 | 17.75 |
| May 06, 2019 | 17.54 |
| May 03, 2019 | 17.14 |
| May 02, 2019 | 17.14 |
| May 01, 2019 | 17.14 |
| April 30, 2019 | 17.49 |
| April 29, 2019 | 17.71 |
| April 26, 2019 | 17.62 |
| April 25, 2019 | 17.71 |
| April 24, 2019 | 17.58 |
| April 23, 2019 | 16.66 |
| April 22, 2019 | 16.70 |
| April 18, 2019 | 16.66 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| NovelStem International Corp. | -- |
| Summit Therapeutics, Inc. | 16.02 |
| Kezar Life Sciences, Inc. | 0.8241 |
| Protara Therapeutics, Inc. | 1.421 |
| Clene, Inc. | -- |
Price to Book Value Related Metrics
| Price | 0.98 |
| Earnings Yield | -97.36% |
| Market Cap | 10.81M |